Retrospective Evaluation of the Efficiency of Therapeutic Plasmapheresis in Thyrotoxic Patients

Year 2022, Volume: 4 - Supplement 1, 93 - 99, 01.04.2022

Filiz Mercan Sarıdaş , Tugce Zor Turna , Ensar Aydemir , Coşkun Ateş , Erhan Hocaoğlu , Soner Cander , Özen Öz Gül , Fahir Özkalemkaş , Erdinç Ertürk , Canan Ersoy

https://doi.org/10.46310/tjim.1073357

Cited By: 1

Abstract

Background: Therapeutic plasma exchange (TPE) is a treatment method that can be used to provide euthyroidism before permanent treatment in patients with severe thyrotoxicosis, in cases of thyroid storm and in cases where antithyroid drug (ATD) cannot be used due to side effects or ineffectiveness. This study presented our results and experience on TPE in thyrotoxic patients.
Material and Methods: The data of 10 patients who underwent plasmapheresis for thyrotoxicosis in Bursa Uludag University Faculty of Medicine Endocrinology Clinic were retrospectively analyzed and compared with the literature.
Results: Ten patients, 6 female and 4 male, were included. The cause of hyperthyroidism was Graves’ disease in 8 patients and toxic multinodular goiter (TMNG) in 2 patients. It was observed that the reason for applying plasmapheresis in the patients was primarily due to toxic hepatitis. The mean number of plasmapheresis required to maintain euthyroidism was 4 (1-8). While no difference was found between the thyroid-stimulating hormone (TSH) results before and after TPE, free T4 (fT4) and free T3 (fT3) values were statistically significantly lower after TPE. It was observed that the leukocytes were considerably higher after TPE and the sodium and calcium values were markedly lower after TPE in the patients. After TPE, 7 patients underwent total thyroidectomy, 1 patient received radioactive iodine (RAI) treatment, and 2 were discharged with ATD treatment.
Conclusions: TPE is an effective and safe treatment option that can be applied in cases where it is necessary to provide rapid euthyroidism before permanent treatments or non-thyroid surgical procedures or to treat life-threatening thyrotoxicosis. It requires experience in application and follow-up and provides rapid euthyroidism when performed in experienced centres.

Keywords

Thyrotoxicosis, therapeutic plasma exchange, hyperthyroidism

References

• Lajtai K, Nagy CT, Tarszabó R, Benkő R, Hadjadj L, Sziva Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343- 421. doi: 10.1089/thy.2016.0229.
• Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association Guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J. 2018 Aug;7(4):167-86. doi: 10.1159/000490384.
• Tieken K, Paramasivan AM, Goldner W, Yuil-Valdes A, Fingeret AL. Therapeutic plasma exchange as a bridge to total thyroidectomy in patients with severe thyrotoxicosis. AACE Clin Case Rep. 2020 Sep 26;6(1):e14-e18. doi: 10.4158/ACCR-2019-0132.
• Tańska K, Leszczyńska D, Glinicki P, Kapuścińska R, Szczepkowski M, Dedecjus M, Stachlewska-Nasfeter E, Brym I, Żelek T, Daniewska D, Gietka-Czernel M. Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life-savingthyroidectomy. J Clin Apher. 2021 Jun;36(3):496-8. doi: 10.1002/jca.21866.
• Muller C, Perrin P, Faller B, Richter S, Chantrel F. Role of plasma exchange in the thyroid storm. Ther Apher Dial. 2011 Dec;15(6):522-31. doi: 10.1111/j.1744-9987.2011.01003.x.
• De Rosa G, Testa A, Menichella G, Cecchini L, Cavallaro A, Mantovani M, Mango G. Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica. 1991 Mar;76 Suppl 1:72-4.
• Guvenc B, Unsal C, Gurkan E, Dincer S. Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report. J Clin Apher. 2004;19(3):148- 50. doi: 10.1002/jca.20014.
• Apaydin T, Gogas Yavuz D. Preoperative plasmapheresis in patients with Graves’ disease intolerant to antithyroid drugs. Ther Apher Dial. 2021 Dec;25(6):877-883. doi: 10.1111/1744-9987.13639.
• Connelly-Smith L, Dunbar NM. The 2019 guidelines from the American Society for Apheresis: What’s new? Curr Opin Hematol. 2019 Nov;26(6):461-465. doi: 10.1097/ MOH.0000000000000534.
• McLeod BC. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol. 2006;19(1):157-67. doi: 10.1016/j.beha.2005.01.004.
• McLeod BC. Plasma and plasma derivatives in therapeutic plasmapheresis. Transfusion. 2012 May;52 Suppl 1:38S-44S. doi: 10.1111/j.1537-2995.2012.03623.x.
• Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long‐term follow‐up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf). 1991 Jan;34(1):71-6. doi: 10.1111/j.1365-2265.1991.tb01738.x.
• Garla V, Kovvuru K, Ahuja S, Palabindala V, Malhotra B, Abdul Salim S. Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review ofthe literature. Case Rep Endocrinol. 2018 Jan 10;2018:4135940. doi: 10.1155/2018/4135940.
• Apaydın T, Elbasan O, Yavuz DG. Preoperative plasmapheresis experience in Graves’ disease patients with anti-thyroid drug-induced hepatotoxicity. Transfus Apher Sci. 2020 Oct;59(5):102826. doi: 10.1016/j. transci.2020.102826.
• Keklik M, Kaynar L, Yilmaz M, Sivgin S, Solmaz M, Pala C, Aribas S, Akyol G, Unluhizarci K, Cetin M, Eser B, Unal A. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study. Transfus Apher Sci. 2013 Jun;48(3):327- 30. doi: 10.1016/j.transci.2013.04.010.
• Simsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG. Therapeutic plasmapheresis in thyrotoxic patients. Endocrine. 2018 Oct;62(1):144-8. doi: 10.1007/ s12020-018-1661-x.
• Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher. 2009;24(3):111-4. doi: 10.1002/jca.20200.
• Vilchez FJ, Torres I, Garcia-Valero A, López-Tinoco C, de Los Santos A, Aguilar-Diosdado M. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole. Ann Pharmacother. 2006 Nov;40(11):2059- 63. doi: 10.1345/aph.1G720.
• Lew WH, Chang CJ, Lin JD, Cheng CY, Chen YK, Lee TI. Successful preoperative treatment of a Graves’ disease patient with agranulocytosis and hemophagocytosis using double filtration plasmapheresis. J Clin Apher. 2011;26(3):159-61. doi: 10.1002/jca.20282.
• Rivas AM, Larumbe E, Thavaraputta S, Juarez E, Adiga A, Lado-Abeal J. Unfavorable socioeconomic factors underlie high rates of hospitalization for complicated thyrotoxicosis in some regions of the United States. Thyroid. 2019 Jan;29(1):27-35. doi: 10.1089/thy.2018.0353.
• Ashkar FS, Katims RB, Smoak WM, Gilson AJ. Thyroid storm treatment with blood exchange and plasmapheresis. JAMA. 1970 Nov 16;214(7):1275-9.
• Tan AWK, Lim BSP, Hoe JKM, Hoi WH, Leow MKS. Therapeutic plasma exchange for control of thyroid storm. J Clin Apher. 2021 Feb;36(1):189-195. doi: 10.1002/jca.21832.
• Adali E, Yildizhan R, Kolusari A, Kurdoglu M, Turan N. The use of plasmapheresis for rapid hormonal control in severe hyperthyroidism caused by a partial molar pregnancy. Arch Gynecol Obstet. 2009 Apr;279(4):569-71. doi: 10.1007/s00404-008-0762-9.
• Azezli A, Bayraktaroglu T, Topuz S, Kalayoglu-Besisik S. Hyperthyroidism in molar pregnancy: Rapid preoperative preparation by plasmapheresis and complete improvement after evacuation. Transfus Apher Sci. 2007 Feb;36(1):87-9. doi: 10.1016/j.transci.2006.05.017.
• Ozdemir Baser O, Cetin Z, Catak M, Koseoglu D, Berker D. The role of therapeutic plasmapheresis in patients with hyperthyroidism. Transfus Apher Sci. 2020 Aug;59(4):102744. doi: 10.1016/j.transci.2020.102744.
• Staniforth JUL, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves’ disease: A meta-analysis. Int J Surg. 2016 Mar;27:118-25. doi: 10.1016/j.ijsu.2015.11.027.
• Bedö Z, Sipka S, Csípö I, Kormos T, Lebedin JS, Shmushkovich BJ, Chuchalin AG, Szegedi G. Leukocytosis induced by plasma exchange. Acta Med Hung. 1991;48(3- 4):219-24.
• Calça R, Gaspar A, Santos A, Aufico A, Freitas P, Coelho S. Therapeutic plasma exchange in patients in a portuguese ICU. Port J Nephrol Hypert 2020;34(1):21-5. doi: 10.32932/ PJNH.2020.04.058.
• Whittaker Striker C, Woldorf S, Holt D. Modification of sodium, glucose, potassium, and osmolarity in packed red blood cells and fresh frozen plasma using a desktop hemoconcentrator setup. J Extra Corpor Technol. 2012 Jun;44(2):60-5.
• Yeh JH, Chen WH, Chiu HC. Complications of double-filtration plasmapheresis. Transfusion. 2004 Nov;44(11):1621-5. doi: 10.1111/j.1537-2995.2004.04154.x.